AAAAAA

   
Results: 1-9 |
Results: 9
Characterization and functional analysis of laminin isoforms in human bonemarrow
Authors: Siler, U Seiffert, M Puch, S Richards, A Torok-Storb, B Muller, CA Sorokin, L Klein, G
Citation: U. Siler et al., Characterization and functional analysis of laminin isoforms in human bonemarrow, BLOOD, 96(13), 2000, pp. 4194-4203
Merosin-positive congenital muscular dystrophy with transient brain dysmyelination, pontocerebellar hypoplasia and mental retardation
Authors: Voit, T Cohn, RD Sperner, J Leube, B Sorokin, L Toda, T Herrmann, R
Citation: T. Voit et al., Merosin-positive congenital muscular dystrophy with transient brain dysmyelination, pontocerebellar hypoplasia and mental retardation, NEUROMUSC D, 9(2), 1999, pp. 95-101
Synergistic activities of alpha 3 and alpha 6 integrins are required during apical ectodermal ridge formation and organogenesis in the mouse
Authors: De Arcangelis, A Mark, M Kreidberg, J Sorokin, L Georges-Labouesse, E
Citation: A. De Arcangelis et al., Synergistic activities of alpha 3 and alpha 6 integrins are required during apical ectodermal ridge formation and organogenesis in the mouse, DEVELOPMENT, 126(17), 1999, pp. 3957-3968
Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAXIS (FRAxiparine in Ischaemic Syndrome)
Authors: Guerrero, RAA Amuchastegui, M Badaracco, J Elizari, M Martellotto, R De la Hoz, RP Ramos, JL Salvati, AM Sinisi, A Torre, H Aroney, G Campbell, T Garrahy, P",Lalman,"Liebens, I Renard, M Bastecky, J Bocek, P Cepelak, V Dvorak, K Gregor, J Janousek, S Jansky, P Jirmar, R Kamenik, L Rybka, J Spacek, R Spinar, J Svitil, P Zeman, K Alagha, Z Allam, S Barnay, C Baudouy, M Beltran, J Berland, J Berthou, JD Bery, E Bessede, G Beygui, F Bickert, P Boshat, J Boulenc, JM Bourlard, P Bouthillier, D Brandt, C Cattan, S Charbonnier, B Citron, B Coisne, D Coupillaud, J Da Costa, A Dambrine, P Danchin, N Delarche, N Dequeker, JL Desjouaux, E Dievart, F Dujardin, JJ Durand, P Fadel, N Fichter, P Galinier, M Gryman, R Gauthier, J Geslin, P Godard, S Grollier, G Guerot, C Gully, C Janin-Manificat, L Joly, P Joseph, T Juillard, A Ketelers, JY Lagorce, P Laine, E Lang, M Lanney-Courten, JE Le Helloco, A Ledru, F Levy, S Litvine-Itaya, L Lopez, M Mansour, M Mathurin, C Meyer, G Mossaz, R Nedelec, G Ollitrault, J Pacouret, G Perchet, H Poitrineau, O Richard, M Rocher, R Rougier, L Sagnol, P Tardieu, A Thery, C Thieuleux, F Touboul, P Tran-Tanh, X Veyrat, A Villarem, D Werquin, S Skoufas, P Fotiadis, I Xenodochidis, C Karidis, K Limberi, S Papasteriadis, E Giokas, K Kremastinos, D Polichronaki, E Moshos, N Daskalakis, I Janecsko, M Janosi, A Kalo, E Karpati, P Mezofi, M Nyaradi, A Ofner, P Oze, B Poor, F Preda, I Ronaszeki, A Valyi, P Zamolyi, K Davini, P Martines, C Melandri, F Pasotti, C Pettinati, G Veze, I Kochkarev, F Erpelding, J Halaczkiewicz, H Ilmuzynska, K Kurowski, M Lasota-Czopnik, A Markiewicz, M Musial, W Nartowicz, E Pasyk, S Prastowski, W Ruszkowski, J Sadowski, Z Sas, M Stopinski, M Ujda, M Wojciechowski, D Diniz, M Drumond, A Rodrigues, P Pereira, MA Correia, A Scherbak, A Irklienko, K Dudko, L Goloschekin, B Maximova, G Sorokin, L Inyushin, A Bzhelianskaia, V Kostenko, V Stefanenko, M Bilich, A Froufe, G Masip, J Pajaron, A Roura, J Sanz, G Valle, V Caduff, B Moccetti, T Noseda, G Simonin, C Baars, HF Bernink, PJLM Daniels, MCG Gobel, E Nagelsmit, MJ Ramdat, AR Senden, PJ van Rossum, P van Wijk, LM Withagen, AJAM Crowe, PF Davidson, C Handler, CE",McNeil,"Molajo, AO
Citation: Raa. Guerrero et al., Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAXIS (FRAxiparine in Ischaemic Syndrome), EUR HEART J, 20(21), 1999, pp. 1553-1562
Secondary reduction of alpha 7B integrin in laminin alpha 2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle
Authors: Cohn, RD Mayer, U Saher, G Herrmann, R van der Flier, A Sonnenberg, A Sorokin, L Voit, T
Citation: Rd. Cohn et al., Secondary reduction of alpha 7B integrin in laminin alpha 2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle, J NEUR SCI, 163(2), 1999, pp. 140-152
Expression of laminin alpha 1, alpha 2, alpha 4, and alpha 5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice
Authors: Ringelmann, B Roder, C Hallmann, R Maley, M Davies, M Grounds, M Sorokin, L
Citation: B. Ringelmann et al., Expression of laminin alpha 1, alpha 2, alpha 4, and alpha 5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice, EXP CELL RE, 246(1), 1999, pp. 165-182
Developmental expression and cellular origin of the laminin alpha 2, alpha4, and alpha 5 chains in the intestine
Authors: Lefebvre, O Sorokin, L Kedinger, M Simon-Assmann, P
Citation: O. Lefebvre et al., Developmental expression and cellular origin of the laminin alpha 2, alpha4, and alpha 5 chains in the intestine, DEVELOP BIO, 210(1), 1999, pp. 135-150
Characterization of bone marrow laminins and identification of alpha 5-containing laminins as adhesive proteins for multipotent hematopoietic FDCP-mix cells
Authors: Gu, YC Sorokin, L Durbeej, M Hjalt, T Jonsson, JI Ekblom, M
Citation: Yc. Gu et al., Characterization of bone marrow laminins and identification of alpha 5-containing laminins as adhesive proteins for multipotent hematopoietic FDCP-mix cells, BLOOD, 93(8), 1999, pp. 2533-2542
Clinical correlations in 16 patients with total or partial laminin alpha 2deficiency characterized using antibodies against 2 fragments of the protein
Authors: Morandi, L Di Blasi, C Farina, L Sorokin, L Uziel, G Azan, G Pini, A Toscano, A Lanfossi, M Galbiati, S Cornelio, F Mora, M
Citation: L. Morandi et al., Clinical correlations in 16 patients with total or partial laminin alpha 2deficiency characterized using antibodies against 2 fragments of the protein, ARCH NEUROL, 56(2), 1999, pp. 209-215
Risultati: 1-9 |